Merck & Company, Inc. (new)

117,40 EUR 1,20 (+1,03%)
Bid 117,40 EUR
Ask 117,80 EUR

Premiumpartner

Firmenbeschreibung

Merck & Co. Inc. ist ein forschungsorientiertes, globales Pharmaunternehmen, das ein breites Sortiment an neuartigen Medikamenten, Impfstoffen und biologischen Therapeutika erforscht, entwickelt, produziert und vermarktet. Das Angebot richtet sich vorwiegend an Krankenhäuser, Apotheken, Einzelhändler, Versicherungen, Regierungsverwaltungen oder institutionelle Einrichtungen aus dem Gesundheitswesen. Des Weiteren bietet Merck & Co. nicht-verschreibungspflichtige Medikamente, Produkte für die Fußpflege und Sonnenschutzmittel sowie Gesundheitsprodukte für Tiere an. Dabei bedient sich das Unternehmen der Biotechnologie, der Genforschung und der Gentherapie. Schwerpunkte sind die Behandlung von Allergien, Atemwegserkrankungen, Infektionskrankheiten, Krebs, Herz- und Kreislauferkrankungen, Erkrankungen des zentralen Nervensystems sowie Hautkrankheiten.

KeyData

endOfFinancialYear: 31.12.2023 00:00
stockholderStructure: Vanguard Group Inc (9.66%),Blackrock Inc. (7.97%),State Street Corp (4.61%),Wellington Management Group Llp (3.38%),Geode Capital Management, Llc (2.19%),Fmr Llc (1.69%),Morgan Stanley (1.58%),Bank Of America Corp /De/ (1.5%),Charles Schwab Investment Management Inc (1.45%),Price T Rowe Associates Inc /Md/ (1.19%)
sharesOutstanding: 2532806307.0000
ceo: Robert M. Davis
board: Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Michael A. Klobuchar, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary, Dean Y. Li, M.D., Ph.D., Chirfi Guindo, Betty Larson
supervisoryBoard: Robert M. Davis, Thomas H. Glocer, Risa J. Lavizzo-Mourey, M.D., Stephen L. Mayo, Ph.D., Paul B. Rothman, M.D., Patricia F. Russo, Christine E. Seidman, M.D., Inge G. Thulin, Kathy J. Warden, Peter C. Wendell, Mary Ellen Coe, Pamela J. Craig, Douglas M. Baker
countryID: 20
freeFloat: 83.8400
faceValue: 0.5000
faceValueCurrencyID: 4
faceValueCurrency: USD
sectorName: Pharmazeutische Industrie
industryName: Gesundheitswesen
subsectorName: Pharmazeutische Industrie
country: USA
countryName: USA

Kontakt

phone: +1-732-594-1468
email: investor_relations@merck.com
irWebSite: https://www.merck.com/investor-relations/

Adresse

street: 126 East Lincoln Avenue
city: Rahway, NJ 07065 USA
phone: +1-908-740-4000
webSite: www.merck.com

Finanzen (kurz)

year: 2021 cash: 8096.0000
balanceSheetTotal: 105694.0000 liabilities: 67437.0000
shareCapital: 1788.0000 totalShareholdersEquity: 38257.0000
sales: 48704.0000 incomeBeforeTaxes: 13879.0000
netIncome: 13049.0000 cashFlow: 14.0000
employees: 68000 currencyID: 4
units: 1000000 currency: USD
year: 2022 cash: 12694.0000
balanceSheetTotal: 109160.0000 liabilities: 63102.0000
shareCapital: 1788.0000 totalShareholdersEquity: 46058.0000
sales: 59283.0000 incomeBeforeTaxes: 16444.0000
netIncome: 14519.0000 cashFlow: 4606.0000
currencyID: 4 units: 1000000
currency: USD
year: 2023 cash: 6841.0000
balanceSheetTotal: 106675.0000 liabilities: 69040.0000
shareCapital: 1788.0000 totalShareholdersEquity: 37635.0000
sales: 60115.0000 incomeBeforeTaxes: 1889.0000
netIncome: 365.0000 cashFlow: -5864.0000
currencyID: 4 units: 1000000
currency: USD

Finanzen (kurz)

year: 2021
cash: 8096.0000
balanceSheetTotal: 105694.0000
liabilities: 67437.0000
shareCapital: 1788.0000
totalShareholdersEquity: 38257.0000
sales: 48704.0000
incomeBeforeTaxes: 13879.0000
netIncome: 13049.0000
cashFlow: 14.0000
employees: 68000
currencyID: 4
units: 1000000
currency: USD
year: 2022
cash: 12694.0000
balanceSheetTotal: 109160.0000
liabilities: 63102.0000
shareCapital: 1788.0000
totalShareholdersEquity: 46058.0000
sales: 59283.0000
incomeBeforeTaxes: 16444.0000
netIncome: 14519.0000
cashFlow: 4606.0000
currencyID: 4
units: 1000000
currency: USD
year: 2023
cash: 6841.0000
balanceSheetTotal: 106675.0000
liabilities: 69040.0000
shareCapital: 1788.0000
totalShareholdersEquity: 37635.0000
sales: 60115.0000
incomeBeforeTaxes: 1889.0000
netIncome: 365.0000
cashFlow: -5864.0000
currencyID: 4
units: 1000000
currency: USD

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 109160.0000 cash: 12694.0000
currentAssets: 35722.0000 fixedAssets: 73438.0000
liabilities: 24239.0000 totalLiabilitiesEquity: 109160.0000
totalShareholdersEquity: 46058.0000 property: 21422.0000
intangibleAssets: 20269.0000 longTermInvestments: 1015.0000
inventories: 5911.0000 accountsReceivable: 9450.0000
accountsPayable: 4264.0000 liabilitiesTotal: 63102.0000
longTermDebt: 28745.0000 shortTermDebt: 1946.0000
minorityInterests: 67.0000 commonStock: 1788.0000
sales: 59283.0000 depreciation: 3885.0000
netIncome: 14519.0000 incomeInterest: -805.0000
investments: 13548.0000 incomeTaxes: 1918.0000
costGoodsSold: 17411.0000 grossProfit: 41872.0000
minorityInterestsProfit: 7.0000 cashFlow: 19095.0000
cashFlowInvesting: -4960.0000 cashFlowFinancing: -9119.0000
cashFlowTotal: 4606.0000 accountingStandard: US GAAP
equityRatio: 42.1931 debtEquityRatio: 137.0055
liquidityI: 52.3701 liquidityII: 91.3569
netMargin: 24.4910 grossMargin: 70.6307
cashFlowMargin: 32.2099 ebitMargin: 0.0000
ebitdaMargin: 0.0000 preTaxROE: 35.7028
preTaxROA: 15.0641 roe: 31.5233
roa: 13.3007 netIncomeGrowth: 11.2652
revenuesGrowth: 21.7210 taxExpenseRate: 11.6638
equityTurnover: 1.2871 epsBasic: 5.7300
epsDiluted: 5.7100 epsBasicGrowth: 11.0465
shareCapital: 1788.0000 incomeBeforeTaxes: 16444.0000
priceEarningsRatioCompany: 19.3630 priceCashFlowRatio: 14.7503
dividendYield: 2.5237 bookValuePerShare: 18.1431
marketCap: 281656834213.6500 earningsYield: 5.1645
pegRatio: 1.7529 cashFlowPerShare: 7.5219
netAssetsPerShare: 18.1695 priceBookValueRatio: 6.1153
dividendsPerShare: 2.8000 priceEarningsRatio: 19.3992
netEarningsPerShare: 5.7193 currency: USD
year: 2023 units: 1000000
balanceSheetTotal: 106675.0000 cash: 6841.0000
currentAssets: 32168.0000 fixedAssets: 74507.0000
liabilities: 25694.0000 totalLiabilitiesEquity: 106675.0000
totalShareholdersEquity: 37635.0000 property: 23051.0000
intangibleAssets: 18011.0000 longTermInvestments: 252.0000
inventories: 6358.0000 accountsReceivable: 10349.0000
accountsPayable: 3922.0000 liabilitiesTotal: 69040.0000
longTermDebt: 33683.0000 shortTermDebt: 1372.0000
minorityInterests: 54.0000 commonStock: 1788.0000
sales: 60115.0000 depreciation: 3844.0000
netIncome: 365.0000 incomeInterest: -781.0000
investments: 30531.0000 incomeTaxes: 1512.0000
costGoodsSold: 16126.0000 grossProfit: 43989.0000
minorityInterestsProfit: 12.0000 cashFlow: 13006.0000
cashFlowInvesting: -14083.0000 cashFlowFinancing: -4810.0000
cashFlowTotal: -5864.0000 accountingStandard: US GAAP
equityRatio: 35.2801 debtEquityRatio: 183.4463
liquidityI: 26.6249 liquidityII: 66.9028
netMargin: 0.6072 grossMargin: 73.1747
cashFlowMargin: 21.6352 ebitMargin: 0.0000
ebitdaMargin: 0.0000 preTaxROE: 5.0193
preTaxROA: 1.7708 roe: 0.9698
roa: 0.3422 netIncomeGrowth: -97.4861
revenuesGrowth: 1.4034 taxExpenseRate: 80.0424
equityTurnover: 1.5973 epsBasic: 0.1400
epsDiluted: 0.1400 epsBasicGrowth: -97.5567
shareCapital: 1788.0000 incomeBeforeTaxes: 1889.0000
priceEarningsRatioCompany: 778.7143 priceCashFlowRatio: 21.2293
dividendYield: 2.7151 bookValuePerShare: 14.8600
marketCap: 276108834925.4400 earningsYield: 0.1284
pegRatio: -7.9822 cashFlowPerShare: 5.1353
netAssetsPerShare: 14.8813 priceBookValueRatio: 7.3365
dividendsPerShare: 2.9600 priceEarningsRatio: 756.4626
netEarningsPerShare: 0.1441 currency: USD
year: 2024 priceEarningsRatioCompany: 915.1429
priceCashFlowRatio: 24.9487 dividendYield: 2.3103
bookValuePerShare: 14.8600 marketCap: 324482332880.6400
earningsYield: 0.1093 pegRatio: -9.3806
cashFlowPerShare: 5.1353 netAssetsPerShare: 14.8600
priceBookValueRatio: 8.6218 priceEarningsRatio: 888.9927
netEarningsPerShare: 0.1441 currency: USD

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 109160.0000
cash: 12694.0000
currentAssets: 35722.0000
fixedAssets: 73438.0000
liabilities: 24239.0000
totalLiabilitiesEquity: 109160.0000
totalShareholdersEquity: 46058.0000
property: 21422.0000
intangibleAssets: 20269.0000
longTermInvestments: 1015.0000
inventories: 5911.0000
accountsReceivable: 9450.0000
accountsPayable: 4264.0000
liabilitiesTotal: 63102.0000
longTermDebt: 28745.0000
shortTermDebt: 1946.0000
minorityInterests: 67.0000
commonStock: 1788.0000
sales: 59283.0000
depreciation: 3885.0000
netIncome: 14519.0000
incomeInterest: -805.0000
investments: 13548.0000
incomeTaxes: 1918.0000
costGoodsSold: 17411.0000
grossProfit: 41872.0000
minorityInterestsProfit: 7.0000
cashFlow: 19095.0000
cashFlowInvesting: -4960.0000
cashFlowFinancing: -9119.0000
cashFlowTotal: 4606.0000
accountingStandard: US GAAP
equityRatio: 42.1931
debtEquityRatio: 137.0055
liquidityI: 52.3701
liquidityII: 91.3569
netMargin: 24.4910
grossMargin: 70.6307
cashFlowMargin: 32.2099
ebitMargin: 0.0000
ebitdaMargin: 0.0000
preTaxROE: 35.7028
preTaxROA: 15.0641
roe: 31.5233
roa: 13.3007
netIncomeGrowth: 11.2652
revenuesGrowth: 21.7210
taxExpenseRate: 11.6638
equityTurnover: 1.2871
epsBasic: 5.7300
epsDiluted: 5.7100
epsBasicGrowth: 11.0465
shareCapital: 1788.0000
incomeBeforeTaxes: 16444.0000
priceEarningsRatioCompany: 19.3630
priceCashFlowRatio: 14.7503
dividendYield: 2.5237
bookValuePerShare: 18.1431
marketCap: 281656834213.6500
earningsYield: 5.1645
pegRatio: 1.7529
cashFlowPerShare: 7.5219
netAssetsPerShare: 18.1695
priceBookValueRatio: 6.1153
dividendsPerShare: 2.8000
priceEarningsRatio: 19.3992
netEarningsPerShare: 5.7193
currency: USD
year: 2023
units: 1000000
balanceSheetTotal: 106675.0000
cash: 6841.0000
currentAssets: 32168.0000
fixedAssets: 74507.0000
liabilities: 25694.0000
totalLiabilitiesEquity: 106675.0000
totalShareholdersEquity: 37635.0000
property: 23051.0000
intangibleAssets: 18011.0000
longTermInvestments: 252.0000
inventories: 6358.0000
accountsReceivable: 10349.0000
accountsPayable: 3922.0000
liabilitiesTotal: 69040.0000
longTermDebt: 33683.0000
shortTermDebt: 1372.0000
minorityInterests: 54.0000
commonStock: 1788.0000
sales: 60115.0000
depreciation: 3844.0000
netIncome: 365.0000
incomeInterest: -781.0000
investments: 30531.0000
incomeTaxes: 1512.0000
costGoodsSold: 16126.0000
grossProfit: 43989.0000
minorityInterestsProfit: 12.0000
cashFlow: 13006.0000
cashFlowInvesting: -14083.0000
cashFlowFinancing: -4810.0000
cashFlowTotal: -5864.0000
accountingStandard: US GAAP
equityRatio: 35.2801
debtEquityRatio: 183.4463
liquidityI: 26.6249
liquidityII: 66.9028
netMargin: 0.6072
grossMargin: 73.1747
cashFlowMargin: 21.6352
ebitMargin: 0.0000
ebitdaMargin: 0.0000
preTaxROE: 5.0193
preTaxROA: 1.7708
roe: 0.9698
roa: 0.3422
netIncomeGrowth: -97.4861
revenuesGrowth: 1.4034
taxExpenseRate: 80.0424
equityTurnover: 1.5973
epsBasic: 0.1400
epsDiluted: 0.1400
epsBasicGrowth: -97.5567
shareCapital: 1788.0000
incomeBeforeTaxes: 1889.0000
priceEarningsRatioCompany: 778.7143
priceCashFlowRatio: 21.2293
dividendYield: 2.7151
bookValuePerShare: 14.8600
marketCap: 276108834925.4400
earningsYield: 0.1284
pegRatio: -7.9822
cashFlowPerShare: 5.1353
netAssetsPerShare: 14.8813
priceBookValueRatio: 7.3365
dividendsPerShare: 2.9600
priceEarningsRatio: 756.4626
netEarningsPerShare: 0.1441
currency: USD
year: 2024
priceEarningsRatioCompany: 915.1429
priceCashFlowRatio: 24.9487
dividendYield: 2.3103
bookValuePerShare: 14.8600
marketCap: 324482332880.6400
earningsYield: 0.1093
pegRatio: -9.3806
cashFlowPerShare: 5.1353
netAssetsPerShare: 14.8600
priceBookValueRatio: 8.6218
priceEarningsRatio: 888.9927
netEarningsPerShare: 0.1441
currency: USD